Endoscopic retrograde cholangiopancreatography-induced severe acute pancreatitis.
OBJECTIVE
There is scant information in the literature about the outcomes of endoscopic retrograde cholangiopancreatography (ERCP)-induced severe acute pancreatitis (ESAP). Compared to other causes, higher morbidity and mortality have been reported in ERCP-induced acute pancreatitis. We undertook this study to determine the differences between ESAP and SAP due to other causes (OSAP).


METHODS
We retrospectively identified all cases of SAP admitted to our institution during the years 1992-2001. We reviewed the medical records of all SAP patients to obtain information on demographics, interventions, local and systemic complications and outcomes.


RESULTS
We identified 207 patients with SAP, of whom 16 (7.7%) had ESAP and 191 OSAP. There was no difference between ESAP and OSAP with regard to demographics, clinical interventions, local and systemic complications and outcomes. Both groups had a similar mortality (25 vs. 18%).


CONCLUSIONS
ESAP has a similar morbidity and mortality compared to OSAP.
Vege
Santhi Swaroop
SS
Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA. vege.santhi@mayo.edu
Chari
Suresh T
ST
Petersen
Bret T
BT
Baron
Todd H
TH
Munukuti
Nagalakshmi
N
Bollineni
Sunitha
S
Rea
Joanna R
JR
D000208:Acute Disease; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D003710:Demography; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D011183:Postoperative Complications; D012189:Retrospective Studies; D016896:Treatment Outcome